543207 — Natural Biocon (India) Cashflow Statement
0.000.00%
- IN₹150.31m
- IN₹152.70m
- IN₹83.48m
Annual cashflow statement for Natural Biocon (India), fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | R2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 0.037 | 0.879 | 2.47 | 2.25 | 0.596 |
| Depreciation | |||||
| Non-Cash Items | — | — | 0 | 0 | -0.05 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 3.21 | 1.06 | -0.366 | -3.5 | 12.4 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 3.24 | 1.94 | 2.1 | -1.25 | 13 |
| Capital Expenditures | — | 0 | 0 | 0 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | 0 | 0 | 0 | -211 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | — | 0 | 0 | 0 | -211 |
| Financing Cash Flow Items | — | 0 | 0 | 0 | 52.6 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -3.22 | -1.54 | -0.186 | -0.885 | 197 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.025 | 0.398 | 1.92 | -2.13 | -1.43 |